114 related articles for article (PubMed ID: 4514552)
1. Bone-marrow toxicity of methotrexate: a reassessment.
Douglas ID; Price LA
Br J Haematol; 1973 May; 24(5):625-31. PubMed ID: 4514552
[No Abstract] [Full Text] [Related]
2. Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B.
JAMA; 1969 Feb; 207(5):923-8. PubMed ID: 4303512
[No Abstract] [Full Text] [Related]
3. Induction of remission in acute leukemia with prednisone and intravenous methotrexate.
Brubaker CA; Gilchrist GS; Hammond D; Hyman CB; Shore NA; Williams KO
J Pediatr; 1968 Oct; 73(4):623-5. PubMed ID: 5245322
[No Abstract] [Full Text] [Related]
4. Complication of methotrexate-maintained remission in lymphoblastic leukemia.
Rawbone RG; Shaw MT; Jackson JG; Bagshawe KD
Br Med J; 1971 Nov; 4(5785):467-8. PubMed ID: 5315979
[No Abstract] [Full Text] [Related]
5. Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia.
Pinkerton CR; Welshman SG; Bridges JM
Br J Cancer; 1982 Feb; 45(2):300-3. PubMed ID: 6949608
[No Abstract] [Full Text] [Related]
6. New treatment schedule with improved survival in childhood leukemia. Intermittent parenteral vs daily oral administration of methotrexate for maintenance of induced remission. Acute leukemia group B.
JAMA; 1965 Oct; 194(1):75-81. PubMed ID: 5896942
[No Abstract] [Full Text] [Related]
7. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate, folate and the brain.
Kamen BA
Neurotoxicology; 1986; 7(2):209-16. PubMed ID: 3097592
[No Abstract] [Full Text] [Related]
9. [Therapeutic management of remissions in acute lymphoblastic leukemia in children].
Armata J
Pol Tyg Lek; 1970 Nov; 25(44):1670-2. PubMed ID: 4921264
[No Abstract] [Full Text] [Related]
10. [Side effects of methotrexate in the treatment of skin diseases].
Ruszczak Z; Prószyńska-Kuczyńska W; Krajewski C
Wiad Lek; 1974 Jun; 27(12):1083-6. PubMed ID: 4600611
[No Abstract] [Full Text] [Related]
11. THE EFFECTS UPON HAEMOPOIESIS OF PROLONGED INTRAARTERIAL INFUSIONS OF METHOTREXATE COMBINED WITH THE INTERMITTENT ADMINISTRATION OF FOLINIC ACID: WITH OBSERVATIONS ON THE PLASMA LEVELS AND URINARY EXCRETION OF METHOTREXATE.
ROSE DP; BOND MR; EVANS C
Br J Cancer; 1965 Mar; 19(1):126-33. PubMed ID: 14284373
[No Abstract] [Full Text] [Related]
12. Letter: Altered plasma pharmacokinetics of methotrexate administered intrathecally.
Jacobs SA; Bleyer WA; Chabner BA; Johns DG
Lancet; 1975 Feb; 1(7904):465-6. PubMed ID: 48664
[No Abstract] [Full Text] [Related]
13. [Clinical-hematological findings in 58 acute leukemias].
Müller D
Med Klin; 1969 Jan; 64(1):13-7. PubMed ID: 5249931
[No Abstract] [Full Text] [Related]
14. Daunorubicin treatment of methotrexate pneumonia.
Pasquinucci G; Ferrara P; Castellari R
JAMA; 1971 Jun; 216(12):2017. PubMed ID: 5281041
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.
Pearson AD; Mills S; Amineddine HA; Long DR; Craft AW; Chessells JM
Cancer Chemother Pharmacol; 1987; 20(3):243-7. PubMed ID: 3315283
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate bioavailability after oral and intramuscular administration in children.
Teresi ME; Crom WR; Choi KE; Mirro J; Evans WE
J Pediatr; 1987 May; 110(5):788-92. PubMed ID: 3471936
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate and folate content of erythrocytes in patients receiving oral vs intramuscular therapy with methotrexate.
Kamen BA; Holcenberg JS; Turo K; Whitehead VM
J Pediatr; 1984 Jan; 104(1):131-3. PubMed ID: 6581287
[No Abstract] [Full Text] [Related]
18. Depression of bone marrow by guanidine.
Norris FH; Eaton JM; Mielke CH
Arch Neurol; 1974 Feb; 30(2):184-5. PubMed ID: 4810899
[No Abstract] [Full Text] [Related]
19. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
Finney R; McDonald GA; Baikie AG; Douglas AS
Br J Haematol; 1972 Sep; 23(3):283-8. PubMed ID: 4507535
[No Abstract] [Full Text] [Related]
20. Effect of nandrolone phenpropionate on myelopoiesis.
Kahn SB; Conroy JF; Brodsky I
J Med; 1974; 5(6):303-9. PubMed ID: 4528544
[No Abstract] [Full Text] [Related]
[Next] [New Search]
